“Healthcare facilities (e.g., hospitals, ambulatory surgical centers, clinics, and doctors’ offices) that utilize reusable medical devices are urged to immediately review current reprocessing practices at their facility to ensure they are complying with all steps as directed by the device manufacturers, and have in place appropriate policies and procedures that are consistent with current standards and guidelines,” FDA representatives wrote.
The steps recommended by the FDA include detailed training protocol for all personnel who reprocess the devices, a regular auditing and feedback system to measure adherence and a general revisiting of facility infection control policies and procedures.
The warning can be found here.
More articles on infection control:
Widespread salmonella outbreak affects more than 300, kills 2
Plague bacteria may have been shipped from government labs
CMS cites lab deficiencies at Cleveland Clinic’s Marymount Hospital
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
